BUSINESS / MARKETS / POLITICS16 November 2026
← Story archive

Markets

Novo says Wegovy injection lowers BMI and obesity rates in children in trial

CNBC

Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.

Read original reporting ↗

Follow the evidence

Read the original report, then compare company disclosures and the relevant official data. A headline alone does not establish an effect on markets.

Coverage timeline

Published reporting in time order

No additional matched coverage has been archived for this story yet.

This page preserves an attributed headline and brief excerpt. The publisher maintains the original report and any subsequent corrections. Report a classification or link issue →